Last $30.11 USD
Change Today -0.98 / -3.15%
Volume 979.1K
AEGR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Antonio M. Gotto Jr., M.D., D.Phil.

Director and Chairman of Nominating & Corporate Governance Committee, Aegerion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 95 board members in 10 different organizations across 7 different industries.

See Board Relationships
78$706,582

Background*

Dr. Antonio M. Gotto, Jr., M.D., D.Phil., is an Advisor at Yellowstone Capital Inc. Dr. Gotto is responsible for Yellowstone Life Sciences at Yellowstone Capital Inc. He serves as a Scientific Advisor at Houston Medical Sciences Limited (HMSL), since its formation in November of 1993. He is Dean Emeritus and Co-Chairman of the Board of Overseers at Weill Cornell Medical College. He serves as the Stephen and Suzanne Weiss Dean of the Joan and Sanford I. Weill Medical ...

Read Full Background

Corporate Headquarters*

101 Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships*

Director
Director
1992-2006
Former Director, Member of Corporate Governance Committee and Member of Technology & Quality Committee
1992-Present
Director
1994-N/A
Former Director
2006-Present
Director and Member of Scientific Advisory Board
2006-Present
Director and Chairman of Nominating & Corporate Governance Committee
2014-Present
Director

Education*

BA
Vanderbilt University
MD
Vanderbilt University
PhD
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$66,500
Total Calculated Compensation$706,582
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $30.11 USD -0.98

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.